[Risk factors for a high carotid intima media thickness among healthy adults]

Mónica Acevedo1, Rodrigo Tagle, Verónica Kramer

  • 1División de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile, Santiago Centro, Chile. macevedo@med.puc.cl

Revista Medica De Chile
|September 1, 2011
PubMed

Insights

Hypertension is the primary risk factor for elevated carotid intima-media thickness (CIMT) and atherosclerotic plaques in healthy adults. Managing blood pressure is crucial for cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Epidemiology

Background:

  • Carotid intima-media thickness (CIMT) serves as a key indicator of subclinical cardiovascular damage.
  • Traditional cardiovascular risk factors significantly influence CIMT progression.
  • Identifying modifiable risk factors is essential for early cardiovascular disease prevention.

Purpose of the Study:

  • To identify and quantify the attributable risk factors associated with elevated CIMT in a healthy adult population.
  • To investigate the specific contribution of hypertension to high CIMT and atherosclerotic plaque formation.

Main Methods:

  • A cohort of 1270 healthy adults (mean age 44 ± 11 years) underwent comprehensive health assessments.
  • Measurements included blood pressure, anthropometrics, lipid profiles, and blood glucose levels.
  • Carotid ultrasound was employed to determine CIMT and detect atherosclerotic plaques, with hypertension, dyslipidemia, and diabetes defined by standard criteria.

Main Results:

  • The mean CIMT was 0.62 ± 0.01 mm, with the 75th percentile at 0.67 mm.
  • Hypertension emerged as the most significant risk factor for CIMT exceeding the 75th percentile (attributable risk 54%).
  • Hypertension also showed a substantial attributable risk (57%) for the presence of atherosclerotic plaques.

Conclusions:

  • Hypertension is identified as the principal modifiable risk factor contributing to increased CIMT in this healthy adult cohort.
  • These findings underscore the critical importance of hypertension management in preventing subclinical atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...